These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15621810)

  • 21. Arsenic trioxide represses NF-kappaB activation and increases apoptosis in ATRA-treated APL cells.
    Mathieu J; Besançon F
    Ann N Y Acad Sci; 2006 Dec; 1090():203-8. PubMed ID: 17384263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATRA and ATO team up against NPM1.
    Grant S
    Blood; 2015 May; 125(22):3369-71. PubMed ID: 26022051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mechanism of synergistic effects of arsenic trioxide and rapamycin in acute myeloid leukemia cell lines lacking typical t(15;17) translocation.
    Dembitz V; Lalic H; Ostojic A; Vrhovac R; Banfic H; Visnjic D
    Int J Hematol; 2015 Jul; 102(1):12-24. PubMed ID: 25758096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells.
    Liu X; Chen J; Yu S; Yan L; Guo H; Dai J; Zhang W; Zhu J
    Cell Death Dis; 2017 May; 8(5):e2782. PubMed ID: 28492552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation.
    Wetzler M; Brady MT; Tracy E; Li ZR; Donohue KA; O'Loughlin KL; Cheng Y; Mortazavi A; McDonald AA; Kunapuli P; Wallace PK; Baer MR; Cowell JK; Baumann H
    Clin Cancer Res; 2006 Nov; 12(22):6817-25. PubMed ID: 17121903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of Bfl-1/A1 in leukemia cells undergoing differentiation by all-trans retinoic acid treatment attenuates chemotherapeutic agent-induced apoptosis.
    Xia L; Wurmbach E; Waxman S; Jing Y
    Leukemia; 2006 Jun; 20(6):1009-16. PubMed ID: 16572199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose arsenic trioxide combined with aclacinomycin A synergistically enhances the cytotoxic effect on human acute myelogenous leukemia cell lines by induction of apoptosis.
    Ye Y; Xu X; Zhang M; Qiu D; Bai X; Wang J; Weng G; Zhou R; Guo Z; He H; Yi W; He X; Guo K
    Leuk Lymphoma; 2015; 56(11):3159-67. PubMed ID: 25739941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of arsenic trioxide or retinoic acid on mRNA and protein expression of tissue factor and thrombomodulin and procoagulant activity in NB4 cells].
    Zhang XH; Hu Y; Hong M; Xia LH; Guo T; Shen GX; Wei WN; Song SJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):391-5. PubMed ID: 17493354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of cucurmosin combined with common chemotherapeutics on proliferation and apoptosis of NB4 cells].
    Xle JM; Liu M; Liu TB; Chen MH; Yang AQ; Yang P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1327-31. PubMed ID: 23257426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia.
    Matsui W; Smith BD; Vala M; Beal N; Huff CA; Diehl LF; Jones RJ
    Br J Haematol; 2005 Mar; 128(6):853-62. PubMed ID: 15755292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug resistance of acute promyelocytic leukemia (APL) to all-trans retinoic acid (ATRA) and its reversion].
    Jiang G; Tang T; Bi K
    Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):154-7. PubMed ID: 11776647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Regulation of all-trans retinoic acid and arsenic trioxide on CD44v6 expression in NB4 cells].
    Huang HF; Chen P; Lu R; Lin ZX; Wu Y; Chen YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):33-7. PubMed ID: 22391160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo.
    Atashrazm F; Lowenthal RM; Dickinson JL; Holloway AF; Woods GM
    Oncotarget; 2016 Jul; 7(29):46028-46041. PubMed ID: 27329592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adhesion molecules and Differentiation Syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia.
    Cunha De Santis G; Tamarozzi MB; Sousa RB; Moreno SE; Secco D; Garcia AB; Lima AS; Faccioli LH; Falcão RP; Cunha FQ; Rego EM
    Haematologica; 2007 Dec; 92(12):1615-22. PubMed ID: 18055984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy.
    Huan SY; Yang CH; Chen YC
    Leuk Lymphoma; 2000 Jul; 38(3-4):283-93. PubMed ID: 10830735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
    Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
    Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
    Lo-Coco F; Avvisati G; Vignetti M; Thiede C; Orlando SM; Iacobelli S; Ferrara F; Fazi P; Cicconi L; Di Bona E; Specchia G; Sica S; Divona M; Levis A; Fiedler W; Cerqui E; Breccia M; Fioritoni G; Salih HR; Cazzola M; Melillo L; Carella AM; Brandts CH; Morra E; von Lilienfeld-Toal M; Hertenstein B; Wattad M; Lübbert M; Hänel M; Schmitz N; Link H; Kropp MG; Rambaldi A; La Nasa G; Luppi M; Ciceri F; Finizio O; Venditti A; Fabbiano F; Döhner K; Sauer M; Ganser A; Amadori S; Mandelli F; Döhner H; Ehninger G; Schlenk RF; Platzbecker U; ; ;
    N Engl J Med; 2013 Jul; 369(2):111-21. PubMed ID: 23841729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catalase activity and arsenic sensitivity in acute leukemia.
    Coe E; Schimmer AD
    Leuk Lymphoma; 2008 Oct; 49(10):1976-81. PubMed ID: 18949620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide.
    Zuo L; Li J; Yang Y; Wang X; Shen T; Xu CM; Zhang ZN
    Ann Hematol; 2004 Dec; 83(12):751-8. PubMed ID: 15480664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.